Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.

Grade Last Price % Change Price Change
F 0.14 -4.13% -0.01
TNXP closed down 4.13 percent on Friday, November 1, 2024, on 40 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -4.13%
Down 3 Days in a Row Weakness -4.13%
Fell Below 20 DMA Bearish -9.78%
Outside Day Range Expansion -9.78%

   Recent Intraday Alerts

Alert Time
Down 5% about 22 hours ago
Down 3% about 22 hours ago
Down 2 % about 22 hours ago
Down 1% about 22 hours ago
Up 5% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman

Is TNXP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.1376
52 Week Low 0.118
Average Volume 30,030,338
200-Day Moving Average 4.22
50-Day Moving Average 0.17
20-Day Moving Average 0.16
10-Day Moving Average 0.17
Average True Range 0.02
RSI (14) 38.65
ADX 21.79
+DI 26.48
-DI 23.07
Chandelier Exit (Long, 3 ATRs) 0.14
Chandelier Exit (Short, 3 ATRs) 0.19
Upper Bollinger Bands 0.19
Lower Bollinger Band 0.13
Percent B (%b) 0.19
BandWidth 40.15
MACD Line -0.01
MACD Signal Line -0.01
MACD Histogram 0.0019
Fundamentals Value
Market Cap 8.17 Million
Num Shares 58.6 Million
EPS -9.26
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 4.85
Price-to-Book 0.16
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.17
Resistance 3 (R3) 0.17 0.16 0.16
Resistance 2 (R2) 0.16 0.15 0.16 0.16
Resistance 1 (R1) 0.15 0.15 0.15 0.15 0.16
Pivot Point 0.14 0.14 0.14 0.14 0.14
Support 1 (S1) 0.13 0.14 0.13 0.13 0.12
Support 2 (S2) 0.13 0.13 0.12 0.12
Support 3 (S3) 0.11 0.13 0.12
Support 4 (S4) 0.11